CORC

浏览/检索结果: 共31条,第1-10条 帮助

已选(0)清除 条数/页:   排序方式:
Clinical features, treatment and risk factors for interstitial pneumonia in B-cell non-Hodgkin lymphoma patients 期刊论文
TRANSLATIONAL CANCER RESEARCH, 2020, 卷号: 9
作者:  Li, Cong;  Lu, Fangxiao;  Lei, Tao;  Yu, Haifeng;  Yang, Haiyan
收藏  |  浏览/下载:22/0  |  提交时间:2020/11/30
Clinical characteristics, treatment patterns and outcomes of patients older than 80years diagnosed with DLBCL in China over a 10-year period 期刊论文
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 卷号: 84, 期号: 1
作者:  Zhuang, Jie;  Shi, Zhan;  Tang, Xi;  Shen, Qianwen;  Chen, Jiayan
收藏  |  浏览/下载:26/0  |  提交时间:2019/12/05
The incidence of HBV reactivation in patients receiving first-line R-CHOP chemotherapy: Three-year follow-up results from a prospective, observational study 期刊论文
Blood, 2017
作者:  
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/05
Primary cutaneous diffuse large B cell lymphomaother successfully treated by the combination of R-CHOP chemotherapy and surgery A case report and review of literature 期刊论文
MEDICINE, 2017, 卷号: 96
作者:  Jia, Jinjing;  Li, Wensheng;  Zheng, Yan
收藏  |  浏览/下载:4/0  |  提交时间:2019/11/26
Novel CHOP activator LGH00168 induces necroptosis in A549 human lung cancer cells via ROS-mediated ER stress and NF-kappa B inhibition 期刊论文
ACTA PHARMACOLOGICA SINICA, 2016, 卷号: 37, 期号: 10, 页码: 1381-1390
作者:  Ma, Yi-ming;  Peng, Yan-min;  Zhu, Qiong-hua;  Gao, An-hui;  Chao, Bo
收藏  |  浏览/下载:25/0  |  提交时间:2019/01/08
Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional study 期刊论文
BMC CANCER, 2016, 卷号: 16
作者:  Wu, Jianqiu;  Song, Yongping;  Su, Liping;  Xu, Li;  Chen, Tingchao
收藏  |  浏览/下载:12/0  |  提交时间:2019/12/04
Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional study 期刊论文
BMC CANCER, 2016, 卷号: 16
作者:  Wu, Jianqiu;  Song, Yongping;  Su, Liping;  Xu, Li;  Chen, Tingchao
收藏  |  浏览/下载:13/0  |  提交时间:2019/12/05
Thalidomide enhanced the efficacy of CHOP chemotherapy in the treatment of diffuse large B cell lymphoma: A phase II study 期刊论文
Oncotarget, 2016, 卷号: Vol.7 No.22, 页码: 33331-33339
作者:  Ji, D.;  Li, Q.;  Cao, J.;  Guo, Y.;  Lv, F.
收藏  |  浏览/下载:3/0  |  提交时间:2019/02/25
Prognostic Significance of Monocytes and Monocytic Myeloid-Derived Suppressor Cells in Diffuse Large B-Cell Lymphoma Treated with R-CHOP 期刊论文
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2016, 卷号: 39, 期号: 2, 页码: 521-530
作者:  Wu, CY;  Wu, XY;  Liu, XN;  Yang, P;  Xu, J
收藏  |  浏览/下载:4/0  |  提交时间:2017/01/10
Expression of activation-induced cytidine deaminase is associated with a poor prognosis of diffuse large B cell lymphoma patients treated with CHOP-based chemotherapy 期刊论文
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 卷号: 142, 期号: 1
作者:  Kawamura, Kiyoko;  Wada, Akihiko;  Wang, Ji-Yang;  Li, Quanhai;  Ishii, Akihiro
收藏  |  浏览/下载:7/0  |  提交时间:2019/12/13


©版权所有 ©2017 CSpace - Powered by CSpace